Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

SCN5A tied to drug-induced cardiac arrythmia

Jan. 18, 2022

Novel genes identified with risk of obsessive-compulsive disorder

Jan. 17, 2022

CD22 aberrant splicing confers resistance to therapy in B-ALL

Jan. 12, 2022

Researchers find novel PTSD-related biomarkers

Jan. 11, 2022

OR5B21 is associated with breast cancer metastasis

Jan. 5, 2022

CIRBP as promising biomarker to identify high-risk patients with IPF

Dec. 22, 2021

IFI27 as a potential new gene biomarker for severe COVID-19

Dec. 21, 2021

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

Dec. 21, 2021

Researchers unveil ACOT13, PTGER2 as candidate genes of autosomal dominant polycystic kidney disease

Dec. 21, 2021

Researchers discover novel genes tied to classical Hodgkin's lymphoma predisposition

Dec. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...